Immobilize 发表于 2025-3-25 06:10:37

Mechanisms of Resistance in Multiple Myeloma,medullary sites. Multi-modality approaches including “novel agents,” traditional chemotherapy, and/or stem cell transplantation are used in MM therapy. Drug resistance, however, ultimately develops and the disease remains incurable for the vast majority of patients. In this chapter, we review both t

enormous 发表于 2025-3-25 09:33:20

http://reply.papertrans.cn/63/6288/628714/628714_22.png

CYT 发表于 2025-3-25 14:15:05

Mario Mandalà,Emanuela RomanoGives an updated overview on the possible reasons of failure of new and promising therapeutic opportunities.Provides extensive discussions of issues including pharmacodynamic and pharmacokinetic mecha

魔鬼在游行 发表于 2025-3-25 16:00:36

Handbook of Experimental Pharmacologyhttp://image.papertrans.cn/m/image/628714.jpg

相同 发表于 2025-3-25 21:46:56

https://doi.org/10.1007/978-3-030-10507-5Drug resistance; Drug mechanisms; Targeted therapy; Immunotherapy; Chemotherapy; antibacterial drug resis

Canvas 发表于 2025-3-26 01:00:23

Springer Nature Switzerland AG 2018

Incisor 发表于 2025-3-26 06:31:37

http://reply.papertrans.cn/63/6288/628714/628714_27.png

反复无常 发表于 2025-3-26 12:01:27

Book 2018 rational therapeutic drug combinations and the use of predictive and prognostic biomarkers to enable patient stratification and tailor treatments. It offers to the readers an updated overview on the possible reasons of failure of new and promising therapeutic opportunities..

琐事 发表于 2025-3-26 13:25:49

Major Physiological Signaling Pathways in the Regulation of Cell Proliferation and Survival,research have suggested that the intrinsic pro-survival signaling crosstalk is the driving force in acquired resistance to a targeted therapy, which may be abolished by interfering with the cross-reacting network.

禁令 发表于 2025-3-26 20:24:37

http://reply.papertrans.cn/63/6288/628714/628714_30.png
页: 1 2 [3] 4 5 6
查看完整版本: Titlebook: Mechanisms of Drug Resistance in Cancer Therapy; Mario Mandalà,Emanuela Romano Book 2018 Springer Nature Switzerland AG 2018 Drug resistan